Results 31 to 40 of about 5,401 (225)

Microneedling combined with pimecrolimus, 5‐fluorouracil, and trichloroacetic acid in the treatment of vitiligo: A comparative study

open access: yesDermatologic Therapy, 2021
Treatment of vitiligo represents a highly therapeutic challenge in spite of the continuous development of new modalities. Combination therapies of vitiligo can help improve treatment response, and reduce recurrence potential.
A. Nofal   +3 more
semanticscholar   +1 more source

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

open access: yesClinical Epidemiology, 2021
Purpose Evidence is insufficient to infer whether topical calcineurin inhibitors (TCIs; tacrolimus and pimecrolimus) cause malignancy. The study objective was to estimate the long-term risk of skin cancer and lymphoma associated with topical TCI use in ...
A. Arana   +17 more
semanticscholar   +1 more source

Terapia tópica com pimecrolimus em lesão cutânea refratária de lúpus eritematoso sistêmico Topical therapy with pimecrolimus in refractory cutaneous lesion of systemic lupus erythematosus

open access: yesRevista Brasileira de Reumatologia, 2006
O rash do lúpus eritematoso sistêmico (LES) é usualmente tratado com corticosteróides tópicos, porém seu uso prolongado causa efeitos adversos cutâneos. Pimecrolimus é um protótipo da classe de agentes imunosupressores tópicos com grande potencial para o
Leandro Vasconcellos Rangel   +4 more
doaj   +1 more source

Forced Degradation Studies Of Pimecrolimus As Per ICH Guidelines

open access: yesJournal of Pharmaceutical Negative Results, 2022
Forced  degradation  studies  are  used  to validate  analytical  procedures  for  the  drug  substance  and degradation products. Forced degradation studies of Pimecrolimus drug substance and its cream were performed  under  the stressed  alkaline ...
NEHA SHARMA AND MUKESH KUMAR GUPTA
semanticscholar   +1 more source

Topical therapy of atopic dermatitis with a focus on pimecrolimus

open access: yesJournal of the European Academy of Dermatology and Venereology, 2021
Atopic dermatitis (AD) is a chronic and relapsing, inflammatory skin disease characterized by impaired skin barrier function and immune system dysregulation that results in dryness, skin microbiome dysbiosis and intense pruritus.
T. Luger   +6 more
semanticscholar   +1 more source

Rosacea-like eruption due to topical pimecrolimus [PDF]

open access: yes, 2015
Topical calcineurin inhibitors have been used outside their approved indications for a number of conditions, including topical steroid-induced rosacea.
Buckley, D A   +3 more
core   +2 more sources

Treatment of Mild to Moderate Plaque Psoriasis with Pimecrolimus, Clobetasol, or Calcipotriol Cream: A comparative study

open access: yesمجلة كلية الطب, 2016
Background: a number of studies have shown that application of topical calcineurin inhibitors is effective for a broad spectrum of inflammatory skin disorders.
Bahir A.R. Mshimesh
doaj   +1 more source

Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort [PDF]

open access: yes, 2006
BACKGROUND: Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use.
Wiesner, A.   +23 more
core   +2 more sources

The Effect of Pimecrolimus Cream 1% Compared with Triamcinolone Acetonide Paste in Treatment of Atrophic-Erosive Oral Lichen Planus [PDF]

open access: yesIranian Journal of Otorhinolaryngology, 2015
Introduction: Oral lichen planus (OLP) is a common chronic mucocutaneous disease. Patients with atrophic and erosive types of OLP often have symptoms of soreness, and require proper treatment.
Atessa Pakfetrat   +4 more
doaj   +2 more sources

Strategies for Selecting Therapeutic Tactics for Reducing Transcutaneous Sensibilisation Risk in Infants with Atopic Dermatitis: Cohort Retrospective Prospective Study

open access: yesПедиатрическая фармакология, 2021
Background. One of the key aspects in the development of atopic dermatitis (AtD) is epidermal barrier dysfunction leading to the penetration of pathogens and allergens through the skin with further body sensibilisation to them.
Dmitri V. Fedorov   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy